Kimberly Clark Corp (KMB), And Three Reasons to Pick This Personal Care Stock

Kimberly Clark Corp (NYSE:KMB) is one of those few stocks that doesn’t need any buzz to outperform the market. The stock has gained about 50% and 33% in the last two years and one year, respectively. Besides, this stock has a quality of consistently distributing dividends to shareholders. All in all, it is a solid stock operating in a niche business, and I have good feelings about this.

In this article, I am going to do a fundamental and operational analysis of the company to discuss three major reasons why the company is able to outperform the market in the long run.

Leadership position in its Niche business

Kimberly Clark Corp (NYSE:KMB) operates in the personal care industry and faces competition from the big names like The Procter & Gamble Company (NYSE:PG) and Johnson & Johnson (NYSE:JNJ). However, because of the niche segment which Kimberly Clark Corp (NYSE:KMB) caters to, it has established itself as a market leader, under some of its products’ categories.

Product categories

Consumer Tissues-

Products offered – facial and bathroom tissue, paper towels. Napkins

Brand name – Cottonelle, Viva, Andrex, Scottex, Hakle

K-C Professional-

Products offered- apparel, wipers, soaps , sanitizers, tissues and towels

Brand name- Kleenex, Scott, WypAll, Kimtech and Jackson Safety

Health Care

Products offered- under pain management and respiratory and digestive health category

Brand names- Kimberly-Clark and ON-Q

Kimberly-Clark Health Care holds leadership position in categories like infection control solutions, surgical solutions, pain management, hygiene solutions and digestive. With brands such as Kleenex, Scott, Huggies, Pull-Ups, Kotex and Depend, Kimberly-Clark holds the No. 1 or No. 2 share position in more than 80 countries

Continual Expansion and Overhauling of operations

In this section, I will discuss some of the company’s expanding and restructuring activities and how these activities are going to help the company in the long run.

Acquisition: Kimberly Clark Corp (NYSE:KMB) is expanding into emerging markets. It acquired the anesthesia business of Life-Tech, a Texas-based medical device manufacturer. This acquisition will enable Kimberly-Clark to capitalize on its leading position in the ON-Q category.

Supply chain restructuring: Kimberly Clark Corp (NYSE:KMB) has been trying to connect its supply chain to the store shelf, for the past six years. The purpose is to create a demand-driven supply chain that would make and warehouse only the precise amount of inventory needed to replace. Main factor behind the demand-supply mismatch was that the company’s store shipments were based on historical sales forecasts, which were not very accurate predictors of future sales. To synchronize this process, the company is planning to use point-of-sale (POS) data from consumer purchase as the basis for replenishment to retailers.

Cost cutting measures in developing and non-performing markets

In developing markets, the company’s net sales increased by 8 percent. This growth came despite a five percent decrease from unfavorable currency translational effect. Sales volumes increased by nine percent in the regions like Brazil, China, Russia and South Korea. Operating profit for the personal care segment in the developing market increased due to higher net sales and cost savings strategy adopted by the company. Besides, the company took a major decision of restructuring in Europe region to maintain its profitability, amidst falling consumer-demand. The restructuring plan will involve the sale or closure of five manufacturing facilities and the reduction of workforce by approximately 1,300 to 1,500 positions.

Fundamentally stronger over its competitors

Kimberly Clark Corp (NYSE:KMB) announced its quarterly results for the first quarter of 2013, performing ahead of expectations. Q1 EPS of $1.48 is $0.15 above the expectation and revenue of $5.32 billion is $0.04 billion ahead of it. Market responded well to the news and the stock jumped about 5% on the announcement day.

Kimberly-Clark has an edge over its competitors like P&G and Johnson & Johnson, fundamentally. Let’s look into the fundamental-details of each one of them to compare.

Procter & Gamble - like Kimberly Clark Corp (NYSE:KMB) is also on bullish trend in the last one year and gained about 30%. Its EPS stands at 4.41, one of the highest in the industry, just next to Kimberly-Clark’s EPS of 4.42. In terms of fundamentals, The Procter & Gamble Company (NYSE:PG) has a P/E ratio of 18.18 while Kimberly-Clark has it at around 22. Price to Book value stands around 3.3 and price to sales at 2.6 for The Procter & Gamble Company (NYSE:PG). Though these figures are impressive but with the net earnings showing a growth of -8.82%, in the previous year consolidated results, the fundamentals don’t augur well for P&G stock.

Johnson & Johnson (NYSE:JNJ) - price to earnings ratio is around 16, price to book value stands around 3.5 and price to sales at 3.4. Here also, with the net earnings decreasing in the previous quarter and having high P/E value, the stock is not expected to show a bullish trend.

For Kimberly-Clark, EPS increased by 12 percent in the previous year and sales increased by three percent. With these growth and healthy fundamental figures, investors can expect the stock’s price to appreciate further.


Conclusion

Kimberly-Clark is one of the few stocks that are able to maintain their price level for more than a year. This stock is still showing an upward trend and there are reasons to believe that the trend is justified. Since the company modified its strategies in the overseas markets and has strong fundamentals, I feel confidently bullish on this stock for the long run.

The article 3 Reasons to Pick This Personal Care Stock originally appeared on Fool.com and is written by Shas Dey.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!